Abstract
SummaryThe prostaglandins, PGE1 and PGE2, effectively inhibit the IgE- and IgGa-mediated release of SRS-A in the rat in a dose-response fashion. Structure-function studies suggest that the carbonyl group in the 9 position, the position of a double bond in the cyclopentane ring, and either the degree of saturation of the cyclopentane ring or the presence of the hydroxl group in the 11 position, or both, are required for optimal inhibitory activity. Indirect evidence did not establish that prostaglandin inhibition of SRS-A release is mediated through an increase in tissue cyclic AMP levels and no synergism between PGE1 and diethylcarbamazine or diso-dium cromoglycate was demonstrable.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
